Results 161 to 170 of about 79,712 (199)
Some of the next articles are maybe not open access.
Genomics of hypertriglyceridemia
2020With regard to heritability of phenotypes, the serum triglyceride level is considered to be highly heritable, with approximately 50% of its variability estimated to derive from parents. Thus, approximately 50% could be modifiable via environmental factors, including lifestyle and medications. Lipoproteins are definitive risk factors for atherosclerotic
Hayato, Tada +2 more
openaire +2 more sources
The American Journal of The Medical Sciences, 1975
The conference opened with the clinical presentation of a 50-year-old male with fasting hyperglycemia (296 mg per cent) and hypertriglyceridemia (2736 mg per cent). The discussion began with a summary of current concepts regarding the manner in which chylomicra (intestine) and very low density lipoproteins (intestine and liver) are formed, transported ...
G M, Reaven, W C, Javorski, E, Reaven
openaire +2 more sources
The conference opened with the clinical presentation of a 50-year-old male with fasting hyperglycemia (296 mg per cent) and hypertriglyceridemia (2736 mg per cent). The discussion began with a summary of current concepts regarding the manner in which chylomicra (intestine) and very low density lipoproteins (intestine and liver) are formed, transported ...
G M, Reaven, W C, Javorski, E, Reaven
openaire +2 more sources
Current Opinion in Endocrinology, Diabetes & Obesity, 2022
Purpose of review Hypertriglyceridemia (HTG) is a risk factor for atherosclerotic cardiovascular disease (ASCVD), aortic stenosis, hepatic steatosis and pancreatitis. We briefly review the aetiology and treatment of HTG and familial chylomicronemia syndrome (FCS), as well as the implementation of a clinical quality registry for
Pang, J. +5 more
openaire +3 more sources
Purpose of review Hypertriglyceridemia (HTG) is a risk factor for atherosclerotic cardiovascular disease (ASCVD), aortic stenosis, hepatic steatosis and pancreatitis. We briefly review the aetiology and treatment of HTG and familial chylomicronemia syndrome (FCS), as well as the implementation of a clinical quality registry for
Pang, J. +5 more
openaire +3 more sources
Hypertriglyceridemia: Impact and Treatment
Endocrinology and Metabolism Clinics of North America, 2009The treatment of elevated levels of low-density lipoprotein cholesterol is standard medical practice supported by conclusive outcome data. Less definitive information exists for hypertriglyceridemia. Only in the setting of severe hyperchylomicronemia is the benefit of triglyceride lowering clear: it is a means to reduce the risk of pancreatitis.
openaire +2 more sources
Wiener medizinische Wochenschrift (1946), 1996
The hypertriglyceridemias comprise a heterogenous group of lipoprotein disorders varying with respect to etiology, lipoprotein pattern, and its major clinical sequelae, i.e. pancreatitis and atherosclerosis. Therefore goals and modalities of treatment should be individualized to a large extent.
B, Föger, J R, Patsch
openaire +1 more source
The hypertriglyceridemias comprise a heterogenous group of lipoprotein disorders varying with respect to etiology, lipoprotein pattern, and its major clinical sequelae, i.e. pancreatitis and atherosclerosis. Therefore goals and modalities of treatment should be individualized to a large extent.
B, Föger, J R, Patsch
openaire +1 more source
Hypertriglyceridemia in pregnancy
Transfusion, 2017Sierra C, Simmons +4 more
openaire +2 more sources